Biotech entity
Artemis II is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Source depth averages 2.5 original sources per story, versus 8.4 across the same-window beat baseline. That works out to roughly 0.9 stories per week across a 16-day span.
Last mentioned: 2d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Artemis II is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Source depth averages 2.5 original sources per story, versus 8.4 across the same-window beat baseline. That works out to roughly 0.9 stories per week across a 16-day span. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. The 6.5 average consequence score is below the beat benchmark of 6.6 in the same window. We currently track 2 Biotech stories that mention NASA, published between July 5, 2026 and July 20, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 59 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NASA. Shared-story counts are live from our verified record — not editorial picks.
First in-orbit medical X-ray
A crewmember aboard a commercial spaceflight captures a diagnostic hand radiograph on day L+1, confirming that diagnostic imaging is possible in sustained orbital microgravity.
Parabolic flight test
Dr. Gifford's team successfully obtains a digital X-ray of a hand in microgravity during a parabolic flight, proving the feasibility of portable X-ray in weightlessness.
The first medical X-ray in space was captured with a compact, battery-powered digital radiography unit, validating a new wave of devices that minimize radiation while delivering diagnostic images. Biotech investors and device manufacturers are eyeing dual-use applications in telehealth and expedition medicine.
Source: hometownregister.com · wyomingnews.com
Spaceflight’s unique physiological challenges — fluid shifts, oxidative stress, nutrient degradation — are driving biotech breakthroughs in personalized nutrition and food preservation. Fresh produce and microbiome research in orbit are now informing terrestrial health solutions.
NASA is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
